These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29962407)

  • 81. The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery.
    Kuang H; Ku SH; Kokkoli E
    Adv Drug Deliv Rev; 2017 Feb; 110-111():80-101. PubMed ID: 27539561
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity.
    Liao D; Liu Z; Wrasidlo W; Chen T; Luo Y; Xiang R; Reisfeld RA
    Nanomedicine; 2011 Dec; 7(6):665-73. PubMed ID: 21419870
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Development of Ultrasound-Triggered and Magnetic-Targeted Nanobubble System for Dual-Drug Delivery.
    Hamarat Şanlıer Ş; Ak G; Yılmaz H; Ünal A; Bozkaya ÜF; Tanıyan G; Yıldırım Y; Yıldız Türkyılmaz G
    J Pharm Sci; 2019 Mar; 108(3):1272-1283. PubMed ID: 30773203
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Design of cyclic RKKH peptide-conjugated PEG liposomes targeting the integrin α₂β₁ receptor.
    Knudsen NØ; Schiffelers RM; Jorgensen L; Hansen J; Frokjaer S; Foged C
    Int J Pharm; 2012 May; 428(1-2):171-7. PubMed ID: 22414425
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.
    Hodgins NO; Al-Jamal WT; Wang JT; Klippstein R; Costa PM; Sosabowski JK; Marshall JF; Maher J; Al-Jamal KT
    J Control Release; 2017 Jun; 256():141-152. PubMed ID: 28432037
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Laminin-derived peptides: Applications in drug delivery systems for targeting.
    Negishi Y; Nomizu M
    Pharmacol Ther; 2019 Oct; 202():91-97. PubMed ID: 31158392
    [TBL] [Abstract][Full Text] [Related]  

  • 87. In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.
    Srinivasan R; Marchant RE; Gupta AS
    J Biomed Mater Res A; 2010 Jun; 93(3):1004-15. PubMed ID: 19743511
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Drug delivery using polyhistidine peptide-modified liposomes that target endogenous lysosome.
    Hayashi T; Shinagawa M; Kawano T; Iwasaki T
    Biochem Biophys Res Commun; 2018 Jun; 501(3):648-653. PubMed ID: 29746864
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Optimizing design parameters of a peptide targeted liposomal nanoparticle in an in vivo multiple myeloma disease model after initial evaluation in vitro.
    Stefanick JF; Omstead DT; Ashley JD; Deak PE; Mustafaoglu N; Kiziltepe T; Bilgicer B
    J Control Release; 2019 Oct; 311-312():190-200. PubMed ID: 31473250
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Pharmacodynamics of liposomes modified with different chain length of sialic acid derivatives].
    Song YZ; Huang ZJ; Luo X; Wang MJ; Zheng JH; Shi J; Deng YH
    Yao Xue Xue Bao; 2016 Feb; 51(2):316-24. PubMed ID: 29856587
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging].
    Kawakami S; Suga T
    Yakugaku Zasshi; 2020; 140(5):633-640. PubMed ID: 32378663
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Elucidation for Intratumor Localization of a DDS-based Anticancer Drug and Enhancement of Its Therapeutic Effects via Improvement of the Tumor Microenvironment].
    Ando H
    Yakugaku Zasshi; 2021; 141(11):1241-1245. PubMed ID: 34719544
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Bioconjugation of Supramolecular Metallacages to Integrin Ligands for Targeted Delivery of Cisplatin.
    Han J; Räder AFB; Reichart F; Aikman B; Wenzel MN; Woods B; Weinmüller M; Ludwig BS; Stürup S; Groothuis GMM; Permentier HP; Bischoff R; Kessler H; Horvatovich P; Casini A
    Bioconjug Chem; 2018 Nov; 29(11):3856-3865. PubMed ID: 30380298
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery.
    Lestini BJ; Sagnella SM; Xu Z; Shive MS; Richter NJ; Jayaseharan J; Case AJ; Kottke-Marchant K; Anderson JM; Marchant RE
    J Control Release; 2002 Jan; 78(1-3):235-47. PubMed ID: 11772464
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Peptide-mediated targeting of liposomes to tumor cells.
    Rezler EM; Khan DR; Tu R; Tirrell M; Fields GB
    Methods Mol Biol; 2007; 386():269-98. PubMed ID: 18604950
    [TBL] [Abstract][Full Text] [Related]  

  • 96. RGD-modified polymer and liposome nanovehicles: Recent research progress for drug delivery in cancer therapeutics.
    Cheng Y; Ji Y
    Eur J Pharm Sci; 2019 Feb; 128():8-17. PubMed ID: 30471410
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment.
    Mikhaylov G; Mikac U; Magaeva AA; Itin VI; Naiden EP; Psakhye I; Babes L; Reinheckel T; Peters C; Zeiser R; Bogyo M; Turk V; Psakhye SG; Turk B; Vasiljeva O
    Nat Nanotechnol; 2011 Aug; 6(9):594-602. PubMed ID: 21822252
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Liposomes in biology and medicine.
    Schwendener RA
    Adv Exp Med Biol; 2007; 620():117-28. PubMed ID: 18217339
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo.
    Sieber S; Grossen P; Detampel P; Siegfried S; Witzigmann D; Huwyler J
    J Control Release; 2017 Oct; 264():180-191. PubMed ID: 28851572
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Can targeted nanoparticles distinguish cancer metastasis from inflammation?
    Choi AS; Moon TJ; Abuhashim W; Bhalotia A; Qian H; Paulsen KE; Lorkowski M; Ndamira C; Gopalakrishnan R; Krishnamurthy A; Schiemann WP; Karathanasis E
    J Control Release; 2023 Oct; 362():812-819. PubMed ID: 37011838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.